Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for Windows
(rifabutin)
2,624 results
  • Primary and secondary antibiotic resistance of Helicobacter pylori in Korea from 2003 to 2018. [Journal Article]
    Helicobacter 2019; :e12660Lee JY, Kim N, … Lee DH
  • CONCLUSIONS: The primary and secondary resistance rates of clarithromycin, metronidazole, and levofloxacin for Helicobacter pylori in Korea were high and increased over time. However, the primary and secondary resistance rates of amoxicillin and tetracycline were low and stable over time. These results will help in selecting effective eradication regimens of H pylori in Korea in the future.
  • Clinical Pharmacodynamics, Pharmacokinetics, and Drug Interaction Profile of Doravirine. [Review]
    Clin Pharmacokinet 2019Boyle A, Moss CE, … Khoo S
  • Doravirine is a novel non-nucleoside reverse transcriptase inhibitor (NNRTI) that has demonstrated good efficacy, tolerability, and safety for the treatment of patients with human immunodeficiency virus (HIV)-1 infection in phase III clinical trials. Doravirine achieved non-inferiority when compared with efavirenz- and darunavir/ritonavir-based regimens. Fewer adverse effects, including neuropsyc…
New Search Next